Literature DB >> 22983008

The transcription factor CREBZF is a novel positive regulator of p53.

Irene López-Mateo1, M Ángeles Villaronga, Susana Llanos, Borja Belandia.   

Abstract

CREBZF is a member of the mammalian ATF/CREB family of transcription factors. Here, we describe a novel functional interaction between CREBZF and the tumor suppressor p53. CREBZF was identified in a yeast two-hybrid screen using HEY1, recently characterized as an indirect p53 activator, as bait. CREBZF interacts in vitro with both HEY1 and p53, and CREBZF expression stabilizes and activates p53. Moreover, CREBZF cooperates synergistically with HEY1 to enhance p53 transcriptional activity. On the other hand, partial depletion of endogenous CREBZF diminishes p53 protein levels and inhibits HEY1-mediated activation of p53. CREBZF-positive effects on p53 signaling may reflect, at least in part, an observed induction of posttranslational modifications in p53 known to prevent its degradation. CREBZF expression protects HCT116 cells from UV radiation-induced cell death. In addition, CREBZF expression confers sensitivity to 5-fluorouracil, a p53-activating chemotherapeutic drug. Our study suggests that CREBZF may participate in the modulation of p53 tumor suppressor function.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983008      PMCID: PMC3495830          DOI: 10.4161/cc.22133

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  35 in total

1.  Targeting of SWI/SNF chromatin remodelling complexes to estrogen-responsive genes.

Authors:  Borja Belandia; Rob L Orford; Helen C Hurst; Malcolm G Parker
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

2.  The effect of Zhangfei on the unfolded protein response and growth of cells derived from canine and human osteosarcomas.

Authors:  T Bergeron; R Zhang; K Elliot; N Rapin; V MacDonald; K Linn; E Simko; V Misra
Journal:  Vet Comp Oncol       Date:  2012-01-15       Impact factor: 2.613

3.  A polymorphic microsatellite that mediates induction of PIG3 by p53.

Authors:  Ana Contente; Alexandra Dittmer; Manuela C Koch; Judith Roth; Matthias Dobbelstein
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

4.  Allelic deletion at chromosome bands 11q14-23 is common in neuroblastoma.

Authors:  J M Maris; C Guo; P S White; M D Hogarty; P M Thompson; D O Stram; R Gerbing; K K Matthay; R C Seeger; G M Brodeur
Journal:  Med Pediatr Oncol       Date:  2001-01

5.  The protein-protein interaction map of Helicobacter pylori.

Authors:  J C Rain; L Selig; H De Reuse; V Battaglia; C Reverdy; S Simon; G Lenzen; F Petel; J Wojcik; V Schächter; Y Chemama; A Labigne; P Legrain
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

Review 6.  The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis.

Authors:  T Hai; M G Hartman
Journal:  Gene       Date:  2001-07-25       Impact factor: 3.688

7.  Chromosomal regions involved in the pathogenesis of osteosarcomas.

Authors:  C Stock; L Kager; F M Fink; H Gadner; P F Ambros
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

Review 8.  Pathological and molecular aspects of prostate cancer.

Authors:  Angelo M DeMarzo; William G Nelson; William B Isaacs; Jonathan I Epstein
Journal:  Lancet       Date:  2003-03-15       Impact factor: 79.321

Review 9.  5-fluorouracil: mechanisms of action and clinical strategies.

Authors:  Daniel B Longley; D Paul Harkin; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

10.  Identification of p53 regulators by genome-wide functional analysis.

Authors:  Qihong Huang; Angel Raya; Paul DeJesus; Sheng-Hao Chao; Kim C Quon; Jeremy S Caldwell; Sumit K Chanda; Juan C Izpisua-Belmonte; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

View more
  17 in total

1.  Effects of cyclic AMP response element binding protein-Zhangfei (CREBZF) on the unfolded protein response and cell growth are exerted through the tumor suppressor p53.

Authors:  Rui Zhang; Vikram Misra
Journal:  Cell Cycle       Date:  2013-11-18       Impact factor: 4.534

2.  Integration of Tumor Genomic Data with Cell Lines Using Multi-dimensional Network Modules Improves Cancer Pharmacogenomics.

Authors:  James T Webber; Swati Kaushik; Sourav Bandyopadhyay
Journal:  Cell Syst       Date:  2018-11-07       Impact factor: 10.304

3.  PLK1 regulates spindle association of phosphorylated eukaryotic translation initiation factor 4E-binding protein and spindle function in mouse oocytes.

Authors:  Ashley L Severance; Keith E Latham
Journal:  Am J Physiol Cell Physiol       Date:  2018-02-22       Impact factor: 4.249

4.  Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.

Authors:  Madhuri Jayathirtha; Anca-Narcisa Neagu; Danielle Whitham; Shelby Alwine; Costel C Darie
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

5.  Zhangfei/CREB-ZF - a potential regulator of the unfolded protein response.

Authors:  Rui Zhang; Noreen Rapin; Zhengxin Ying; Erika Shklanka; Timothy W Bodnarchuk; Valerie M K Verge; Vikram Misra
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

6.  The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.

Authors:  Rui Zhang; Douglas H Thamm; Vikram Misra
Journal:  BMC Vet Res       Date:  2015-02-07       Impact factor: 2.741

7.  Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.

Authors:  Ji-Min Lee; Gil-Tae Gang; Don-Kyu Kim; Yong Deuk Kim; Seung-Hoi Koo; Chul-Ho Lee; Hueng-Sik Choi
Journal:  J Biol Chem       Date:  2013-11-21       Impact factor: 5.157

8.  The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity.

Authors:  Shoubao Ma; Jiazhuo Yan; Tasha Barr; Jianying Zhang; Zhenhua Chen; Li-Shu Wang; Joseph C Sun; Jianjun Chen; Michael A Caligiuri; Jianhua Yu
Journal:  J Exp Med       Date:  2021-06-23       Impact factor: 17.579

9.  Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage.

Authors:  T Ozaki; D Wu; H Sugimoto; H Nagase; A Nakagawara
Journal:  Cell Death Dis       Date:  2013-04-25       Impact factor: 8.469

10.  Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.

Authors:  Ling Li; Zijun Y Xu-Monette; Chi Young Ok; Alexandar Tzankov; Ganiraju C Manyam; Ruifang Sun; Carlo Visco; Mingzhi Zhang; Santiago Montes-Moreno; Karen Dybkaer; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Jinfen Wang; Ben M Parsons; Jane N Winter; Miguel A Piris; Lan V Pham; L Jeffrey Medeiros; Ken H Young
Journal:  Oncotarget       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.